• Corpus ID: 74091881

Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley

@inproceedings{SalazarVzquez2014FinasteridePD,
  title={Finasteride para disminuir el sangrado en resecci{\'o}n transuretral de pr{\'o}stata en pacientes con sonda Foley},
  author={J Alberto Salazar-V{\'a}zquez and Juan Antonio Lugo-Garc{\'i}a},
  year={2014}
}
Introduction. The bening prostatic hiperplasia (BPH) is a non cancerous growth of the prostatic gland binded the age, and the hormonal secretion. This is responsible above the main of urinary symptoms in most men, usually when shifting the 50-year-old. In patients with obstructive prostatic growth are treated by surgery, the intraoperative bleeding is one of the complications that present and difficult surgery, as well as complicate the postoperative. The finasteride is an enzyme inhibitor of 5… 

References

SHOWING 1-10 OF 13 REFERENCES

The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group.

The effects of finasteride in patients with benign prostatic hyperplasia were investigated in 2 double-blind, placebo-controlled studies, finding lower doses had a lesser effect on prostate shrinkage.

Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia

This study evaluated the efficacy of finasteride for the treatment of gross hematuria secondary to benign prostatic hyperplasia in a prospective fashion and found it to be safe and effective.

[Prostatic diseases].

  • P. Bischoff
  • Medicine
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis
  • 1971
This book is referred to read because it is an inspiring book to give you more chance to get experiences and also thoughts and it will show you the best book collections and completed collections.